Humana Inc. (NYSE:HUM) Shares Acquired by Willner & Heller LLC

Willner & Heller LLC boosted its position in Humana Inc. (NYSE:HUM) by 28.2% in the 4th quarter, HoldingsChannel reports. The firm owned 2,002 shares of the insurance provider’s stock after purchasing an additional 440 shares during the period. Willner & Heller LLC’s holdings in Humana were worth $508,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Liberty One Investment Management LLC acquired a new position in shares of Humana during the fourth quarter worth $822,000. Clarius Group LLC raised its holdings in Humana by 7.0% in the fourth quarter. Clarius Group LLC now owns 905 shares of the insurance provider’s stock valued at $230,000 after acquiring an additional 59 shares in the last quarter. Canoe Financial LP acquired a new stake in shares of Humana during the fourth quarter worth $62,000. Merit Financial Group LLC raised its holdings in shares of Humana by 16.6% during the fourth quarter. Merit Financial Group LLC now owns 1,819 shares of the insurance provider’s stock worth $461,000 after purchasing an additional 259 shares during the period. Finally, Avanza Fonder AB bought a new position in shares of Humana during the fourth quarter worth about $2,524,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages recently issued reports on HUM. Leerink Partnrs lowered shares of Humana from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 2nd. Sanford C. Bernstein upgraded shares of Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price objective on the stock in a research note on Tuesday, October 8th. Leerink Partners cut Humana from an “outperform” rating to a “market perform” rating and cut their price objective for the company from $400.00 to $250.00 in a report on Wednesday, October 2nd. Truist Financial lifted their price objective on Humana from $260.00 to $290.00 and gave the company a “hold” rating in a report on Monday, January 6th. Finally, Wells Fargo & Company lowered their price objective on Humana from $387.00 to $290.00 and set an “overweight” rating for the company in a research report on Monday, November 4th. Twenty analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Hold” and a consensus price target of $302.70.

Humana Stock Performance

Shares of NYSE HUM opened at $282.63 on Monday. The firm has a market cap of $34.03 billion, a price-to-earnings ratio of 25.03, a P/E/G ratio of 2.02 and a beta of 0.55. Humana Inc. has a one year low of $213.31 and a one year high of $415.73. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.76 and a quick ratio of 1.76. The stock’s fifty day moving average price is $273.81 and its two-hundred day moving average price is $307.57.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, topping the consensus estimate of $3.48 by $0.68. Humana had a return on equity of 13.20% and a net margin of 1.18%. The business had revenue of $29.30 billion during the quarter, compared to the consensus estimate of $28.66 billion. On average, equities analysts forecast that Humana Inc. will post 16.14 EPS for the current year.

Humana Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be given a $0.885 dividend. The ex-dividend date is Tuesday, December 31st. This represents a $3.54 annualized dividend and a yield of 1.25%. Humana’s dividend payout ratio is presently 31.36%.

Insider Buying and Selling

In related news, insider Timothy S. Huval sold 3,703 shares of Humana stock in a transaction on Tuesday, December 31st. The stock was sold at an average price of $256.26, for a total transaction of $948,930.78. Following the sale, the insider now directly owns 8,181 shares in the company, valued at approximately $2,096,463.06. This trade represents a 31.16 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.29% of the stock is currently owned by insiders.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.